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Abstract
Airway wall thickening and mucus plugging are important characteristics of cystic
fibrosis (CF) lung disease in the first 5 years of life.The aim of this study is to
investigate the association of lung disease in preschool children (age, 2‐6) with
bronchiectasis and other clinical outcome measures in the school age (age >7).
Deidentified computed tomography‐scans were annotated using Perth‐Rotterdam
annotated grid morphometric analysis for CF. Preschool %disease (a composite
score of %airway wall thickening, %mucus plugging, and %bronchiectasis) and %
MUPAT (a composite score of %airway wall thickening and %mucus plugging) were
used as predictors for %bronchiectasis and several other school‐age clinical
outcomes. For statistical analysis, we used regression analysis, linear mixed‐
effects models and two‐way mixed models. Sixty‐one patients were included.
%Disease increased significantly with age (P < .01). Preschool %disease and
%MUPAT were significantly associated with school‐age %bronchiectasis (P < .01
and P < .01, respectively). No significant association was found between
preschool %disease and %MUPAT and school‐age forced expiratory volume 1
(FEV1%) predicted and quality of life (P > .05). Cross‐sectional, %disease in
school‐age was associated with a low FEV1% predicted and low quality of life
(P = .01 and P = .007, respectively). %Disease can be considered an early marker
of diffuse airways disease and is a risk factor for school‐age bronchiectasis.
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1 | INTRODUCTION
Cystic fibrosis (CF) lung disease is characterized by chronic airway
inflammation and infection, leading to early structural changes
of the airways, such as airway wall thickening and mucus plugging.1-3
These changes are thought to lead to the development of bronchiectasis,
which is defined as an irreversible widening of the airway.2
Chest computed tomography (CT) is currently the most sensitive
method to detect structural changes of the airways in children.1,4
Bronchiectasis on CT in children is diagnosed when the outer diameter of
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the airway is larger than the adjacent artery and/or when a lack of
tapering can be observed.5-7 Multiple image analysis systems have been
developed to quantify structural lung changes in CT. Using these systems,
bronchiectasis was validated as a clinically relevant CT related outcome
measures in many studies.8-12 In addition, bronchiectasis in school‐age
children is considered a clinically important outcome measure in CF lung
disease.2,9,13 It was shown that the extent of bronchiectasis is associated
with more pulmonary exacerbations and lower quality of life in school‐
aged children.8,9,14-17 Furthermore, it has been well established that
spirometry parameters have poor sensitivity to detect and monitor
bronchiectasis.18,19 In today’s CF populations that have well‐preserved
lung function, bronchiectasis still increases over time in school‐age
children as well as in adults, which can occur even when forced
expiratory volume 1 (FEV1) does not show significant changes.
9,19,20
However, to date in preschool children, the usefulness of a bronchiectasis
score as an outcome measure for CF lung disease is less clear. Even
though bronchiectasis is present in 60% to 80% of the children with CF in
the school‐age,21 the extent and severity of bronchiectasis in preschool
children are generally lower (29.3%‐61.5%) and therefore not considered
a sensitive outcome measure for clinical studies and patient care in this
age group.4,14,22 However, diffuse airway abnormalities such as airway
wall thickening, and mucus plugging are observed in many preschool
children.23 It is hypothesized that these preschool airway changes reflect
diffuse airway disease that eventually will result in bronchiectasis in the
school age.
To quantify early structural lung changes, the Perth‐Rotterdam
annotated grid morphometric analysis for CF (PRAGMA‐CF) was
developed for the sensitive assessment of structural airway
abnormalities in CF children below the age of 6 years.4 An important
PRAGMA‐CF outcome measure is the composite score %disease
which includes airway wall thickening, mucus plugging, and bronch-
iectasis all three reflecting airway disease, but which are often
difficult to differentiate in the preschool age. It was shown that %
disease is a reproducible and precise way of assessing airway
disease.4 To validate %disease it was compared in school‐age
children to two other established image analysis methods, namely
the CF‐CT method and the airway‐artery (AA) ratio method.13 %
Disease correlated well to both CF‐CT outcomes and AA‐outcomes,
reflecting airway disease.13
To further validate %disease as a clinically relevant outcome
measure for preschool CF lung disease it is important to investigate
whether it is associated with school‐age bronchiectasis.
The overall aim of this study was to investigate the association
of %disease in the preschool age with the development of
bronchiectasis and other clinical outcome measures at school
age. We hypothesized that %disease assessed by PRAGMA‐CF in
the preschool age is a risk factor for the development of later
bronchiectasis, for a lower FEV1% predicted, for a lower quality of
life and for the development of exacerbations. To do so we studied
the association of %disease on routinely acquired chest CTs in
preschool children with the prevalence of bronchiectasis on
routine CTs of these children in school age. In addition, we
studied the association value of %disease with pulmonary
exacerbations, FEV1% predicted, and health‐related quality of life.
Finally, we investigated the cross‐sectional association between %
disease in school‐age and FEV1 and quality of life.
2 | METHODS
2.1 | Study population
For this longitudinal and retrospective study, we used clinical data
acquired at the routine annual evaluations of patients with CF who
were followed at the Erasmus Medical Center (MC)—Sophia
Children’s Hospital (Rotterdam, The Netherlands) which is a tertiary
care university hospital. The CF center takes care on average of 150
children with CF up to the age of 19 years. Newborn screening was
introduced in May 2011. In annual benchmarking studies as part of
the Dutch and European CF registry, our center ranks in the upper
quartile for outcome measures such as FEV1 and body mass index.
The following inclusion criteria were applied: (a) a confirmed CF
diagnosis by sweat test and genetic testing, (b) informed consent is
given by the patient and/or the parent or legal guardian for using
clinical data (protocol MEC2013‐338), (c) availability of at least 2
volumetric biennials CT scans acquired at the annual examination: a
preschool CT scan made between the age of 2 and 6 years and the
most recent spirometer controlled or technician guided school‐age
CT scan made at the age of 7 years or older. Patients that had a
respiratory exacerbation at the time of CT scan were excluded. The
data used for this study was collected retrospectively, from the
routinely acquired data of the Sophia Children’s cohort. This study
was approved by the ethical review board of the Erasmus MC—
Sophia Children’s Hospital (MEC2013‐338).
2.2 | Chest CT protocol and evaluation
From 1999 up to 2004 a biennial sequential CT protocol was used for
monitoring the patients with CF. This protocol was replaced by a
volumetric CT protocol in 2004. CTs were performed on different CT
scanners using low‐dose protocols. From 2007 and onwards, a new
CT‐scanner became available, that was fast enough to obtain near
motion free volumetric CT scans in nearly all free‐breathing
preschool children. From 2007 and onwards most of the school‐
aged volumetric CT scans were spirometer controlled. This protocol
was introduced in our hospital to optimize and standardize volume
during acquisition.24 In short, all school‐age patients are trained to
undertake the CT breath‐hold maneuvers before the CT scan and the
instructions during the scan are given by the same lung function
technician who provided the training. Spirometer controlled CT scans
are composed of a volumetric inspiratory scan and a volumetric
expiratory scan. Inspiratory scans are performed during a breath‐
hold at maximum inspiration. Expiratory scans are performed during
a breath‐hold at maximum expiration. When due to logistic reasons
CT could not be spirometer controlled, breath‐hold maneuvers were
trained and guided by the lung function technician during the CT, but
without the spirometer. For those children in the preschool age not
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able to do a breath‐hold maneuver, a CT scan was obtained while the
child was free breathing. CT scanning was done in a supine position,
with arms positioned over the head. CT scans in preschool children
were free‐breathing in 57 out of the 61 eligible children, spirometer
controlled in 1 and technician guided in 3 children. CT scans in
school‐age children were technician guided in 4 children and
spirometer controlled in 57 children. The first biennial CT scans
were executed at the age of 2 years until 2007 after which we
changed to execute the first scan at the age of 1 year based on the
Australian Respiratory Early Surveillance Team for Cystic Fibrosis
(AREST‐CF) findings. Biennial scanning is continued until children
reach adulthood and are transferred to the CF team for adults in the
Erasmus MC or elsewhere.
2.3 | Image analysis
Before annotating the CT scans, all scans were deidentified and
randomized. All CT scans were annotated by one certified observer
(NB) with more than 2 years of scoring experience. To assess
intraobserver agreement, a subset of 20 randomly selected CT scans
was rescored by the observer 1 month after scoring the complete CT
dataset. To assess interobserver agreement, a subset of 20 randomly
selected CT scans were scored by a different observer (CM).
The PRAGMA‐CF scoring system has been extensively described
elsewhere.4 In short, a grid is overlaid on 10 equally spaced axial
slices of a volumetric chest CT.4 The size of the grid cells overlaying
the CT scan is adjusted for the patient’s size by measuring the
horizontal distance of the lung parenchyma on the axial slice closest
to the carina. This distance is divided by 20 to set the grid size. All
grid cells on each slice are annotated using a hierarchical system in
the following order: (a) healthy, (b) bronchiectasis, (c) mucus plugging,
(d) abnormal, (e) atelectasis, (f) trapped air. Abnormal representing
airway wall thickening. annotating of each grid cell is only allowed
when the grid cell contains at least 50% lung parenchyma.4 For each
of the scored items, the volume fraction of the scored component is
expressed as a percentage of total lung volume, %disease is
computed as the sum of %bronchiectasis, %mucus plugging, and %
airway wall thickening, reflecting all components related to airways
disease. For this study, we also computed an additional PRAGMA‐CF
composite score: %MUPAT. This score consists of the sum of %mucus
plugging, and %airway wall thickening, which was used to study the
association with school‐age bronchiectasis of airway disease compo-
nents, without the confounding contribution of %bronchiectasis.
Important to note is that as %bronchiectasis, %mucus plugging, %
airway wall thickening, and %disease represent % of total lung
volume they are small but they can represent a large number of
affected airways.
2.4 | Clinical outcome measures
For all patients the following clinical data were collected from the
electronic patient records.
2.4.1 | Spirometry
Spirometry was executed using the ERS‐ATS guidelines. FEV1 was
expressed as %predicted using the global lung function 2012
equations.8,25,26 The spirometry data that was closest to the last
CT scan (maximum 2 months apart) was used for further analysis.
2.4.2 | Exacerbations
Because no universally accepted definition of a pulmonary exacerbation
is available,27 we selected the same conservative approach as used in
previous similar studies, defining an exacerbation as the number of
episodes of treatment with IV antibiotics for increased pulmonary
symptoms. Using this definition, a positive correlation was observed in
several studies between bronchiectasis as scored using the CF‐CT scoring
method and the number of exacerbations in patients with CF.8,15,28 For
our cohort the number of exacerbations was counted from the date of
the preschool CT up to the date of the school‐age CT scan. For our
statistical analysis, we also divided patients into two groups, one group
that had one or more exacerbations and the other group that had no
exacerbations between CT scans.
2.4.3 | Quality of life
To measure the quality of life at the time of the school‐age CT we
used the CF quality of life revised (CFQ‐R) tool29: the child version
for children aged 6 to 13; the teen/adult version for patients above
14 years old.27,30 For our analysis we evaluated only the respiratory
domain of the CFQ‐R, as it is most directly related to the severity of
lung disease.16,28 The CFQ‐R scores can vary between 0 and 100,
with a higher score reflecting a better health‐related quality of life.
2.5 | Statistical analysis
The descriptive statistics were done using SPSS/PC Statistics
21.0 (SPSS Inc Chicago, IL), and the statistical software package R
(free download from www.rproject.org) version 3.3.1. Continuous
variables are presented as mean and categorical variables as
percentages.
Regression analysis was performed to investigate the association
between the covariates and the outcomes of interest. In particular,
we investigated
• The association between %disease at preschool age, the CT‐
scanner used at preschool age, the age at preschool, with the
outcomes: FEV1% predicted, quality of life, and bronchiectasis
(linear regression).
• The association between %MUPAT, the CT‐scanner used at
preschool age, the age at preschool, with the outcomes: FEV1%
predicted, quality of life, and bronchiectasis (linear regression).
• The cross‐sectional association between %disease at school age,
with the outcomes: FEV1% predicted, quality of life, and
bronchiectasis (linear regression).
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The dataset consists of some outliers, therefore sensitivity
analysis was performed to investigate whether the outliers will
influence the results. We, furthermore, investigated some transfor-
mations of the outcomes, in the example the Wilcoxon rank‐sum test
to check sensitivity to the assumptions of the other models. From the
analysis with and without the outliers and the different transforma-
tions of the outcomes, we obtained the same conclusions.
The relationship between %disease at preschool age and whether
a patient experienced no or at least one exacerbation episode from
preschool until school age was assessed using a logistic regression
model. Linear mixed‐effects models were used for the %disease
outcome to assess changes between preschool and one school‐age
measurement. The advantage of these models is that they can work
with unbalanced data collection times (as in our case datasets with
varying times between repeated measurements of each subject).31
Furthermore, they take into account that measurements from the
same patient may be more correlated than measurements from
different patients. Two‐way mixed‐effects models were used to
determine the intraclass correlation, a score above 0.70 was
considered to be a good agreement.31 Correction for multiple testing
was not performed. Two‐sided P < .05 were considered to be
statistically significant.
3 | RESULTS
3.1 | Study population
The Sophia Children’s cohort includes follow‐up data of 187 patients
available at the time of data collection. Sixty‐one patients were
included in our current study having met all inclusion criteria
(Figure 1). Eighty‐two patients were excluded, because they did
not have a volumetric CT scan available in the preschool age.
Furthermore, 36 patients were excluded, because they were still too
young (<7 years old) at the time of data collection and therefore did
not have a school‐age volumetric CT scan available. Eight patients
were excluded, because they had less than one CT scan available at
the time of inclusion (for various reasons, such as changing hospitals).
Patient characteristics are shown in Table 1.
In total 122 CT scans were annotated using the PRAGMA‐CF
method. CTs were made on six different CT scanners (Table S2a+b
online supplement [OLS]). CFQ‐R data and spirometry at the last
school‐age CT were available for all 61 patients. The intraclass
correlation coefficients (ICC) for intraobserver and interobserver
agreement for the PRAGMA‐CF score for %disease and %bronch-
iectasis were, respectively, 0.91 and 0.70, and 0.93 and 0.83.
3.2 | PRAGMA‐CF scores and clinical outcomes
Between preschool and school‐age, %disease increased significantly.
In addition, positive associations between preschool CT scores %
disease and %MUPAT, and school‐age %bronchiectasis score were
observed (Table 2). Also, linear mixed models showed a significant
increase (P < .01) in %disease over time (Figure 2). Preschool %
disease and %MUPAT were not significantly associated with school‐
age FEV1% predicted and CFQ‐R.
Multivariable linear regression models showed a significant
association after correcting for age at school age and type of CT‐
scanner used at preschool between %disease at preschool and %
F IGURE 1 Study flowchart. CF, cystic fibrosis; CT, computed
tomography
TABLE 1 Patient characteristics
Characteristics Preschool School age
Number of patients 61
Sex, male (%) 32 (52.4)
Age, y 4.07 (3.25, 4.67) 10.65 (8.75, 11.83)
Time between scans, y 6.58 (5.08, 8.08)
Respiratory subscores
%Disease 0.7 (0, 0.98) 1.73 (0.28, 2.86)
%MUPAT 0.46 (0, 0.51) 0.58 (0, 0.82)
%Bronchiectasis 0.23 (0, 0.29) 1.15 (0, 1.43)
FEV1 (%) predicted NA 89.93 (76.5, 97.3)
Quality of life
(CFQ‐R score)
NA 76.26 (67, 92)
Number of exacerbations – 0.72 (0, 1)
Genotype
F508 del/F508 del (%) 61
F508 del/other (%) 38
Other/other (%) 2




Mean courses of IV
antibiotics (range)
Birth to preschool CT 0.44 (0, 5) 0.75 (0, 9)
Preschool CT to
school‐age CT
Note: Patient characteristics at the time of the preschool and last school‐
age CT scan. Data are presented as no. (%) or mean (interquartile range).
Abbreviations: CF, cystic fibrosis; CT, computed tomography; CFQ‐R,
CF quality of life revised; FEV1, forced expiratory volume 1; NA, not
available.
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bronchiectasis at school age (Table 2). An increase of 1% in %
disease at the preschool age, resulted in an increase of 1.18%
(P < .001) in %bronchiectasis at school age. The effects of age at
preschool age and the CT‐scanner used at preschool had no
significant effect on the outcomes.
When the bronchiectasis component was excluded from %
disease the association between %MUPAT and %bronchiectasis at
school age remained significant (P < .001; Table 2). Cross‐sectional
analysis at school age showed significant associations between %
disease and FEV1%predicted (P = .01) and CFQ‐R (P = .007; Table 2).
Of the 61 patients, 19 patients had one or more pulmonary
exacerbations that required a course of IV antibiotics in the period
between preschool and school age. No significant association
between %disease at preschool and exacerbations could be found
(P = .19; Table S4 of the OLS).
4 | DISCUSSION
Our key finding is that %disease in the preschool age established by
PRAGMA‐CF is associated with bronchiectasis in school age.
Importantly, the association was still significant for %MUPAT
excluding preschool %bronchiectasis. These findings are in line with
previous studies in school‐aged children that showed, that mucus
plugging is associated with inflammation and airway wall thickening
and that these are thought to be risk factors for later bronchiectasis.2
Our findings are also in line with previous findings using a
sensitive image analysis method for the objective measurement of
AA dimensions (AA‐method) of all visible AA pairs on a CT scan.6,13 In
preschool children the AA‐method showed diffuse widening and
progressive thickening of the airways in patients with CF in the
Australian AREST‐CF cohort. On the basis of these studies, it was
suggested that bronchiectasis represents the tip of the iceberg of
underlying diffuse airway disease that starts early in life. In school‐
age children, it was shown that bronchiectasis, as detected by the
AA‐method, correlated well to bronchiectasis detected by the
PRAGMA‐CF scoring method.32 %Disease is a composite score that
includes all key morphological changes visible on CT related to
airway disease. Thickening of the airway wall is visible on chest CT
may be the result of inflammation, and/or mucous attached to the
airway wall and both features are captured in %MUPAT. On the basis
of our findings, we suggest that %disease and %MUPAT could be
TABLE 2 Multivariable linear regression analysis
%Bronchiectasis school age FEV1% predicted school age CFQ‐R school age
Estimate 95% CI P Estimate 95% CI P Estimate 95% CI P
%Disease preschool 1.18 0.82 to 1.54 <.001 −2.12 −7.35 to 3.10 .42 −1.57 −6.19 to 3.05 .50
%MUPAT preschool 1.58 1.12 to 2.03 <.001 −3.45 −10.20 to 3.30 .31 −2.09 −8.03 to 3.86 .49
Cross‐sectional analysis
%Disease school age NA NA NA −2.79 −4.98 to −0.60 .01 −2.81 −4.82 to −0.80 .007
Note: A multivariable linear regression was used, where we corrected for the CT‐scanner used at preschool age and for the age at school age.
Abbreviations: CF, cystic fibrosis; CI, confidence interval; CT, computed tomography; CFQ‐R, CF quality of life revised; FEV1, forced expiratory volume 1;
NA, not available.
F IGURE 2 %Disease over time. This
figure shows the progression of %disease
of individual patients from their preschool
CT up to the moment of their last school‐
age CT. The black solid line represents the
average evolution over time obtained by
the linear regression model, while the
dashed lines represent the confidence
intervals. CT, computed tomography
[Color figure can be viewed at
wileyonlinelibrary.com]
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used as a clinically relevant outcome measure in clinical studies in
preschool patients with CF, as these measures predict later
bronchiectasis. %Disease may be preferred as it captures all
the principal features of CF airways disease including bronchiectasis.
%Bronchiectasis by itself, however, is a less suitable outcome
measure in clinical studies in preschool children, as the extent of
bronchiectasis in these children is low. In addition, in early CF lung
disease in preschool children, it can be difficult to distinguish by
eyeballing between a widened and thickened bronchiectatic airway
and an airway showing only airway wall thickening.
As supported by our data, %disease captures all the relevant
morphological changes of airways in one composite score.
It is important to notice that the %bronchiectasis component of %
disease increased over time. This increase in absolute number might
seem to be small but that is related to the fact that %bronchiectasis
represents the absolute volume fraction of the lung occupied by
bronchiectatic airways (Figure S3, OLS).
Similarly, %disease represents the volume fraction of the lung
occupied by diseased airways. For example for a patient with a low %
disease score of 0.2% at the preschool age, 121 grid cells contained
airways, only 3 out of these 121 airways (=2.5%) contained abnormal
airways. While at follow‐up, %disease was 0.6% and 230 grid cells
contained airways, 11 out of these 230 airways (=4.7%) were
considered to be abnormal. For a patient with a higher %disease
score of 3.4% at the preschool age, 146 grid cells contained airways,
50 out of these 146 airways (=30%) were considered to be abnormal.
At the school‐age %disease increased to 5.8% and 186 grid cells
contained airways, 100 out of these 186 airways (=53%) were
considered to be abnormal. Hence, %disease captures well the
extend of airways disease and tracks progression over time, making it
an important outcome measure for randomized controlled trials
investigating the effectiveness of drugs that aim to halt progression
or reverse CF lung disease. However, %disease as a number might
not be right away meaningful for the clinician. Unfortunately,
currently, the PRAGMA‐CF software does not automatically gen-
erate the absolute number of cells containing normal airways or
airways showing bronchiectasis, airway wall thickening, or mucus
plugging. For future development of the software, it would be
meaningful for clinicians to generate in addition to %disease also the
total number of airways counted and the percentage of abnormal
airways. For an example of the progression of structural lung disease
over time see Figure S4 of the OLS.
We did not observe an association between preschool %
disease and later FEV1. This is in line with previous studies in older
children where over 2 year time intervals it was shown that chest
CT scores showed the significant progression of structural
abnormalities, while spirometry outcomes such as FEV1, did not
show significant changes.9,18
For clinical studies in early or milder CF disease, it will,
therefore, be important to include a direct measurement of lung
structure such as chest CT. Whether progression of structural
lung abnormalities from the preschool age into school age can
be tracked more sensitively using lung clearance index relative
to spirometry outcomes needs to be further investigated in
longitudinal studies that include both multiple breath washout
and routine chest CT.
No association between preschool %disease and the occurrence
of pulmonary exacerbations was found. In previous studies
including a larger number of patients, we have observed a
correlation between bronchiectasis as scored by CF‐CT and
exacerbations defined as courses of IV antibiotics.33 Due to the
inclusion criteria, our current cohort is smaller and of a more recent
period in time. These patients, therefore, have less advanced
disease relative to previous cohorts and require less courses of IV
antibiotics. Hence, it is no surprise that we did not observe a
correlation between %disease and courses of IV antibiotics.
The regression analysis showed that %disease in the preschool
age was not significantly associated with school‐age CFQ‐R
respiratory domain scores. This contrasts with earlier longitudinal
studies in school‐aged children, where it was shown that bronch-
iectasis scores were a predictor of later lower quality of life as
measured by CFQ‐R. This may be related to the fact that our cohort
was younger and had less severe airway disease compared with older
and less recent cohorts from previous studies.28,34
However, in the cross‐sectional analysis at the time of school‐age
CT, we did observe a negative association between %disease and %
predicted FEV1, and the CFQ‐R respiratory domain scores. This was
to be expected as children with more advanced structural damage on
CT are more likely to have a lower lung function and quality of life.
We acknowledge some limitations to our study. First, this study
was executed in a single‐center, which could mean that the
population we studied is not representative for the general CF
population. In the European Cystic Fibrosis Society Patient
Registry, our center has clinical outcome measures, in the upper
range (thus healthier) and structural abnormalities are therefore
likely to be less severe compared with other centers. Second, the
analysis includes 61 subjects out of the full cohort of 179 subjects.
These were all available consecutive subjects that met all inclusion
criteria. Most patients were excluded because of them not having
a volumetric CT scan at the right age available (Figure 1). Also,
there were differences in the CT protocol and CT scanners used
for the preschool and school‐age CT scans. At preschool CT scans,
most CT scans were acquired supervised by a lung function
technician, but without the use of a spirometer. Most school‐age
CTs were technician and spirometer controlled, thus optimizing
inspiratory lung volume. Therefore, the scans taken at the school‐
age were likely to be more sensitive for the detection of
bronchiectasis, compared with preschool CT scans. These differ-
ences in technique might have influenced the observed progres-
sion of %disease. On the one hand, the ability to pick up
bronchiectasis in children between 1 and 5 years at functional
residual capacity (FRC) has been shown to be reduced relative to
total lung capacity (TLC) CTs.7 On the other hand, in preschool and
in school‐age children the severity of bronchiectasis on expiratory
scans in school‐age children correlates well to the severity of
bronchiectasis on scans taken at full inspiration.32,35 More
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importantly, it has been shown in preschool children that the
sensitivity to pick up airway wall thickening is better on FRC scans
relative to TLC scans.6 Even though differentiation between its
components is proven difficult, %disease is a composite score that
includes both airway wall thickening and bronchiectasis, so
differentiation between its components seems to be less relevant
to capture relevant airway disease leading to later bronchiectasis.
It is likely that we underestimate the true association between
preschool %disease and school‐age %bronchiectasis in our real‐life
study due to differences in CT scanners and imaging and
reconstruction protocols over the 13 years observational period.
However, visual scoring methods such as PRAGMA‐CF are
considered less affected by such technical influences. In addition,
the lower level of lung volume standardization for the preschool
CT might have reduced our ability to identify bronchiectasis
diseased airways at low lung volume levels. However, the
sensitivity to detect airway wall thickening at lower lung volumes
is better relative to high lung volumes.6 %Disease has been
identified as a reproducible and sensitive PRAGMA‐CF outcome
measure for assessing early CF lung disease as it sums up the three
most important components of early airways disease being: %
airway wall thickening, %mucus plugging, and %bronchiectasis
making it less dependent on variation in lung volume level.4
In this study we decided not to include trapped air as an outcome
measure as the primary aim of in this cohort was to investigate the
predictive value of early visible airway changes (%disease) for later
bronchiectasis. However, for future studies, it may be worth
investigating if this could also be a sensitive marker for the future
development of bronchiectasis.
The use of routine biennial chest CT outcomes for monitoring CF
lung disease in young children includes a small risk related to the
repeated exposure to ionizing radiation.36 As CF is a genetic disease
with high morbidity and mortality, the use of CT imaging in patients
with CF is thought to have a favorable risk‐benefit ratio. The findings
of this study add further evidence in support of this view.
In conclusion, in preschool children, %disease measured by
PRAGMA‐CF on chest CT allows quantification of early clinically
relevant morphological features of CF airway disease and it is
associated with later school‐age bronchiectasis. In addition, the
progression of %disease was observed in this cohort. These findings
support the use of %disease as a clinical relevant outcome measure in
early CF lung disease.
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